Mariangela Tripodi
Mariangela Tripodi has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Raffaele Ferri
Oasi Research Institute-IRCCS, 94018 Troina, Italy
14 shared publications - Bartolo Lanuzza
Oasi Research Institute-IRCCS, Troina, Italy
13 shared publications - Filomena Irene Ilaria Cosentino
IRCCS Oasi, Troina (Enna), Italy
12 shared publications - Rosario Sebastiano Spada
Oasi Institute for Research on Mental Retardation and Brain Aging (IRCCS), Troina, Italy
7 shared publications G. Toscano
Geriatric Unit, “Oasi” Institute for Research on Mental Retardation and Brain Aging (I.R.C.C.S.), Via Conte Ruggero n. 73, I-94018 Troina (EN), Italy
5 shared publicationsI. Iero
Neurology Unit, “Oasi” Institute for Research on Mental Retardation and Brain Aging (I.R.C.C.S.), Via Conte Ruggero n. 73, I-94018 Troina (EN), Italy
4 shared publications
Latest Publications
- 7 April 2026
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 22 (1)
Dream-enactment behaviors without REM sleep without atonia
To compare clinical and polysomnographic features of patients with isolated REM sleep behavior disorder (iRBD) and patients with clinically reported dream-enactment behaviors (DEB) occurring in the absence of REM sleep without atonia (RSWA), and to clarify the clinical significance of DEB without RSWA. We retrospectively reviewed clinical records and polysomnography of consecutive patients referred to a tertiary sleep and neurology center. Twenty-six patients with polysomnography-confirmed iRBD, 21 patients with DEB without RSWA, and 24 control subjects were included. Clinical features related to prodromal neurodegeneration, neuroimaging findings, sleep architecture, REM atonia indices, limb movements, and respiratory parameters were analyzed using age-adjusted comparisons with effect size estimation. Compared with DEB patients, iRBD patients were older and showed a higher prevalence of subtle extrapyramidal signs, lower cognitive performance, and a greater burden of vascular neuroimaging abnormalities. Clinically reported hyposmia and depression were infrequent and did not differ between groups. Both clinical groups exhibited increased sleep fragmentation and instability, most pronounced in iRBD, with DEB patients showing intermediate values. REM atonia robustly differentiated groups, whereas periodic limb movements during sleep and respiratory disturbance did not differ significantly after age adjustment. DEB occurring without RSWA are associated with a clinical and polysomnographic profile distinct from iRBD, characterized by preserved REM atonia and a lower burden of markers linked to prodromal neurodegeneration. These findings highlight the heterogeneity of DEB and support characterization beyond conventional RBD diagnostic criteria. Current knowledge/study rationale: Isolated REM sleep behavior disorder (iRBD) is defined by dream-enactment behaviors (DEB) with REM sleep without atonia (RSWA), whereas clinically reported DEB without RSWA presents a diagnostic challenge and unclear significance in relation to prodromal neurodegeneration. Study impact: In this retrospective tertiary-center cohort, iRBD patients had more extrapyramidal signs, lower cognitive performance, and greater vascular imaging abnormalities compared with DEB without RSWA, whereas both groups showed increased sleep instability. These findings highlight that DEB without RSWA has a distinct clinical and polysomnographic profile, supporting the need for characterization beyond conventional RBD diagnostic criteria.
- 7 April 2026
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 22 (1)
Dream-enactment behaviors without REM sleep without atonia
To compare clinical and polysomnographic features of patients with isolated REM sleep behavior disorder (iRBD) and patients with clinically reported dream-enactment behaviors (DEB) occurring in the absence of REM sleep without atonia (RSWA), and to clarify the clinical significance of DEB without RSWA. We retrospectively reviewed clinical records and polysomnography of consecutive patients referred to a tertiary sleep and neurology center. Twenty-six patients with polysomnography-confirmed iRBD, 21 patients with DEB without RSWA, and 24 control subjects were included. Clinical features related to prodromal neurodegeneration, neuroimaging findings, sleep architecture, REM atonia indices, limb movements, and respiratory parameters were analyzed using age-adjusted comparisons with effect size estimation. Compared with DEB patients, iRBD patients were older and showed a higher prevalence of subtle extrapyramidal signs, lower cognitive performance, and a greater burden of vascular neuroimaging abnormalities. Clinically reported hyposmia and depression were infrequent and did not differ between groups. Both clinical groups exhibited increased sleep fragmentation and instability, most pronounced in iRBD, with DEB patients showing intermediate values. REM atonia robustly differentiated groups, whereas periodic limb movements during sleep and respiratory disturbance did not differ significantly after age adjustment. DEB occurring without RSWA are associated with a clinical and polysomnographic profile distinct from iRBD, characterized by preserved REM atonia and a lower burden of markers linked to prodromal neurodegeneration. These findings highlight the heterogeneity of DEB and support characterization beyond conventional RBD diagnostic criteria. Current knowledge/study rationale: Isolated REM sleep behavior disorder (iRBD) is defined by dream-enactment behaviors (DEB) with REM sleep without atonia (RSWA), whereas clinically reported DEB without RSWA presents a diagnostic challenge and unclear significance in relation to prodromal neurodegeneration. Study impact: In this retrospective tertiary-center cohort, iRBD patients had more extrapyramidal signs, lower cognitive performance, and greater vascular imaging abnormalities compared with DEB without RSWA, whereas both groups showed increased sleep instability. These findings highlight that DEB without RSWA has a distinct clinical and polysomnographic profile, supporting the need for characterization beyond conventional RBD diagnostic criteria.
- 5 February 2024
- Published by Springer Nature in Current Sleep Medicine Reports
- Vol. 10 (2) , 207-216
A Topical Review on Transcranial Magnetic Stimulation in Restless Legs Syndrome
- 5 February 2024
- Published by Springer Nature in Current Sleep Medicine Reports
- Vol. 10 (2) , 207-216
A Topical Review on Transcranial Magnetic Stimulation in Restless Legs Syndrome
- 1 July 2011
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 125 (5) , 319-325
Absence of cardiovascular disease risk factors in restless legs syndrome
Restless legs syndrome (RLS) might represent a condition at risk of cardiovascular (and cerebrovascular) disease; the role of sleep periodic leg movements, sleep deprivation, and presence of common risk factors for heart disease in these patients remains to be determined. The aim of this study was to evaluate the eventual presence of risk factors for cerebrovascular disease in RLS. Eighty-seven consecutive patients affected by idiopathic RLS were included in this study together with 81 controls. Blood count, chemistry, and kidney function tests were obtained. We detected subjects suffering from diabetes mellitus, kidney diseases, heart diseases, disk herniation, neuropathy, blood diseases, liver diseases, artery diseases, dyslipidemia, or hypertension. Polysomnography was recorded in 66 patients, and cerebral neuroimaging was obtained in 59 patients with RLS. None of the differences in blood test parameters was statistically significant; however, hypertension was found to be more frequent in controls and dyslipidemia was more frequent in patients with RLS, but this was explained by its higher frequency in patients also affected by obstructive sleep apnea. A diagnosis of cerebrovascular disease was posed for 14 patients with RLS (16.1%), but no predictive factor for its presence was found at the binomial logistic regression. Our findings argue against the presence of an altered lipid metabolism as a risk factor for the development of cerebrovascular disease in patients with RLS, even if they do support the idea that cerebrovascular disease might be frequent in this condition.
- 1 July 2011
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 125 (5) , 319-325
Absence of cardiovascular disease risk factors in restless legs syndrome
Restless legs syndrome (RLS) might represent a condition at risk of cardiovascular (and cerebrovascular) disease; the role of sleep periodic leg movements, sleep deprivation, and presence of common risk factors for heart disease in these patients remains to be determined. The aim of this study was to evaluate the eventual presence of risk factors for cerebrovascular disease in RLS. Eighty-seven consecutive patients affected by idiopathic RLS were included in this study together with 81 controls. Blood count, chemistry, and kidney function tests were obtained. We detected subjects suffering from diabetes mellitus, kidney diseases, heart diseases, disk herniation, neuropathy, blood diseases, liver diseases, artery diseases, dyslipidemia, or hypertension. Polysomnography was recorded in 66 patients, and cerebral neuroimaging was obtained in 59 patients with RLS. None of the differences in blood test parameters was statistically significant; however, hypertension was found to be more frequent in controls and dyslipidemia was more frequent in patients with RLS, but this was explained by its higher frequency in patients also affected by obstructive sleep apnea. A diagnosis of cerebrovascular disease was posed for 14 patients with RLS (16.1%), but no predictive factor for its presence was found at the binomial logistic regression. Our findings argue against the presence of an altered lipid metabolism as a risk factor for the development of cerebrovascular disease in patients with RLS, even if they do support the idea that cerebrovascular disease might be frequent in this condition.
- 1 December 2008
- Published by Elsevier in Sleep Medicine
- Vol. 9 (8) , 831-839
The APOE ε4 allele increases the risk of impaired spatial working memory in obstructive sleep apnea
- 1 December 2008
- Published by Elsevier in Sleep Medicine
- Vol. 9 (8) , 831-839
The APOE ε4 allele increases the risk of impaired spatial working memory in obstructive sleep apnea
- 26 August 2008
- Published by Elsevier in Sleep Medicine
- Vol. 10 (3) , 312-316
Subclinical abnormal EMG activation of the gastrocnemii during gait analysis in restless legs syndrome: A preliminary report in 13 patients
- 26 August 2008
- Published by Elsevier in Sleep Medicine
- Vol. 10 (3) , 312-316
Subclinical abnormal EMG activation of the gastrocnemii during gait analysis in restless legs syndrome: A preliminary report in 13 patients
- 31 December 2007
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 44, 381-384
Low total cholesterol predicts mortality in the nondemented oldest old
- 31 December 2007
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 44, 381-384
Low total cholesterol predicts mortality in the nondemented oldest old
- 20 August 2007
- Published by Wiley in European Journal of Neurology
- Vol. 14 (9) , 1016-1021
A single question for the rapid screening of restless legs syndrome in the neurological clinical practice
The purposes of this study were to validate the use of a single standard question for the rapid screening of restless legs syndrome (RLS) and to analyze the eventual effects of the presence of RLS on self‐assessed daytime sleepiness, global clinical severity and cognitive functioning. We evaluated a group of 521 consecutive patients who accessed our neurology clinic for different reasons. Beside the answer to the single question and age, sex, and clinical diagnosis, the following items were collected from all patients and normal controls: the four criteria for RLS, the Epworth Sleepiness Scale (ESS), the Clinical Global Impression of Severity (CGI‐S), and the Mini‐Mental State evaluation. RLS was found in 112 patients (70 idiopathic). The single question had 100% sensitivity and 96.8% specificity for the diagnosis of RLS. ESS and CGI‐S were significantly higher in both RLS patient groups than in normal controls. RLS severity was significantly higher in idiopathic than in associated/symptomatic RLS patients. RLS can be screened with high sensitivity and good reliability in large patient groups by means of the single question; however, the final diagnosis should always be confirmed by the diagnostic features of RLS and accompanied by a careful search for comorbid conditions.
- 20 August 2007
- Published by Wiley in European Journal of Neurology
- Vol. 14 (9) , 1016-1021
A single question for the rapid screening of restless legs syndrome in the neurological clinical practice
The purposes of this study were to validate the use of a single standard question for the rapid screening of restless legs syndrome (RLS) and to analyze the eventual effects of the presence of RLS on self‐assessed daytime sleepiness, global clinical severity and cognitive functioning. We evaluated a group of 521 consecutive patients who accessed our neurology clinic for different reasons. Beside the answer to the single question and age, sex, and clinical diagnosis, the following items were collected from all patients and normal controls: the four criteria for RLS, the Epworth Sleepiness Scale (ESS), the Clinical Global Impression of Severity (CGI‐S), and the Mini‐Mental State evaluation. RLS was found in 112 patients (70 idiopathic). The single question had 100% sensitivity and 96.8% specificity for the diagnosis of RLS. ESS and CGI‐S were significantly higher in both RLS patient groups than in normal controls. RLS severity was significantly higher in idiopathic than in associated/symptomatic RLS patients. RLS can be screened with high sensitivity and good reliability in large patient groups by means of the single question; however, the final diagnosis should always be confirmed by the diagnostic features of RLS and accompanied by a careful search for comorbid conditions.
- 1 January 2006
- Published by Elsevier in Sleep Medicine
- Vol. 7 (1) , 63-71
The neurophysiology of the alternating leg muscle activation (ALMA) during sleep: Study of one patient before and after treatment with pramipexole
- 1 January 2006
- Published by Elsevier in Sleep Medicine
- Vol. 7 (1) , 63-71
The neurophysiology of the alternating leg muscle activation (ALMA) during sleep: Study of one patient before and after treatment with pramipexole
- 2 December 2005
- Published by Wiley in Journal of Sleep Research
- Vol. 14 (4) , 463-470
Agrypnia excitata in a patient with progeroid short stature and pigmented Nevi (Mulvihill‐Smith syndrome)
Summary: We report the video‐polysomnographic sleep characteristics of a 25‐year‐old woman with the Mulvihill‐Smith syndrome, a rare clinical condition characterized by progeria‐like aspect, peculiar multiple pigmented nevi, low stature, and cognitive impairment. Among the various exams, two overnight video‐polysomnographic recordings were carried out; moreover, cerebral MRI and molecular analysis of the prion protein gene (PRNP) were also performed. The video‐polysomnographic recordings showed the absence of clear sleep episodes but the presence of periods during which the patient had poor contact with the environment, stereotyped afinalistic movements of the upper limbs and hands, irregular or periodic breathing (with central apnea episodes), heart rate arrhythmia, and rapid eye movements. Cerebral MRI showed only diffuse mild enlargement of the cortical sulci and the molecular genetics analysis of the PRNP was normal. Our clinical and neurophysiological study seems to indicate that a particular condition of severe sleep disruption, similar to some extent to that reported in the fatal familial insomnia and in the Morvan fibrillary chorea, which has been indicated as Agrypnia Excitata in recent literature, might be associated with the Mulvihill‐Smith syndrome. The inclusion of a detailed study on the sleep characteristics of eventual additional patients will certainly help our understanding of this rare condition.
- 2 December 2005
- Published by Wiley in Journal of Sleep Research
- Vol. 14 (4) , 463-470
Agrypnia excitata in a patient with progeroid short stature and pigmented Nevi (Mulvihill‐Smith syndrome)
Summary: We report the video‐polysomnographic sleep characteristics of a 25‐year‐old woman with the Mulvihill‐Smith syndrome, a rare clinical condition characterized by progeria‐like aspect, peculiar multiple pigmented nevi, low stature, and cognitive impairment. Among the various exams, two overnight video‐polysomnographic recordings were carried out; moreover, cerebral MRI and molecular analysis of the prion protein gene (PRNP) were also performed. The video‐polysomnographic recordings showed the absence of clear sleep episodes but the presence of periods during which the patient had poor contact with the environment, stereotyped afinalistic movements of the upper limbs and hands, irregular or periodic breathing (with central apnea episodes), heart rate arrhythmia, and rapid eye movements. Cerebral MRI showed only diffuse mild enlargement of the cortical sulci and the molecular genetics analysis of the PRNP was normal. Our clinical and neurophysiological study seems to indicate that a particular condition of severe sleep disruption, similar to some extent to that reported in the fatal familial insomnia and in the Morvan fibrillary chorea, which has been indicated as Agrypnia Excitata in recent literature, might be associated with the Mulvihill‐Smith syndrome. The inclusion of a detailed study on the sleep characteristics of eventual additional patients will certainly help our understanding of this rare condition.
- 1 April 2004
- Published by Springer Nature in Neurological Sciences
- Vol. 25 (1) , 30-33
Isolated monolateral neurosensory hearing loss as a rare sign of neuroborreliosis
- 1 April 2004
- Published by Springer Nature in Neurological Sciences
- Vol. 25 (1) , 30-33
Isolated monolateral neurosensory hearing loss as a rare sign of neuroborreliosis